Home > Healthcare > Pharmaceuticals > Finished Drug Form > North America and Europe PEGylated Drugs Market

North America and Europe PEGylated Drugs Market Size

  • Report ID: GMI2511
  • Published Date: Apr 2018
  • Report Format: PDF

North America and Europe PEGylated Drugs Market Size

North America & Europe PEGylated Drugs Market size was valued over USD 7.7 billion in 2017 and is expected to witness more than 5% CAGR from 2018 to 2024.

 

North America & Europe PEGylated Drugs Market

To understand key trends  
Download Free Sample
 

Rising prevalence of chronic diseases including cancer in developed regions coupled with increasing R&D spending by pharmaceutical and biotechnology companies will drive the PEGylated drugs market size. As per American Cancer Society, over 15.5 million Americans are living with cancer and more than 1.7 million new cases are anticipated to be diagnosed in 2018. This will foster demand for PEGylated drugs in the future.

 

Growing biologics sector such as, new advances in cell therapies, immunotherapies, antibody drug conjugates, gene therapies will offer immense growth opportunities in the future. Increasing acceptance of biologics drugs such as, monoclonal antibodies, colony stimulating factors, and interferons for treatment of chronic diseases will upsurge revenue share of PEGylated drugs in developed regions. However, drug recalls and adverse drug reactions associated with pegylated drugs will hinder business growth during the forecast timeframe.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of North America and Europe pegylated drugs valued over USD 7.7 billion in 2017.

The industry share of North America and Europe pegylated drugs is expected to witness more than 5% CAGR from 2018 to 2024.

North America & Europe PEGylated Drugs Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2017
  • Companies covered: 10
  • Tables & Figures: 39
  • Countries covered: 6
  • Pages: 100
 Download Free Sample